Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 23,094 shares at $6.42 ($148K) on 2020-02-25, disclosed to the SEC on 2020-02-28.
Seasonal sale ($148k) by Chief Operating Officer — this insider has traded STML in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.42 | 11,547 | $74K | 50.0% |
| 2 | $6.42 | 11,547 | $74K | 50.0% |
| Total | $6.42 avg | 23,094 | $148K | 100% |
| Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |
| STML | SELL | 2020-01-03 | $937K | — | Filing → |